General MedicationsTOPICALStandard
ADQUEY
DIFAMILAST
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ADQUEY is listed in Drugs@FDA under application 219474 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DIFAMILAST Form and strength OINTMENT;TOPICAL - 1% Sponsor ACROTECH BIOPHARMA Submission history Latest submission status date: 2026-02-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview ADQUEY is listed in Drugs@FDA under application 219474 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DIFAMILAST Form and strength OINTMENT;TOPICAL - 1% Sponsor ACROTECH BIOPHARMA Submission history Latest submission status date: 2026-02-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.